Results 231 to 240 of about 78,758 (356)

Ultrasound elastography to guide compression therapy for gastrocnemius trigger points in runners. [PDF]

Sci Rep
Landfald IC, Podgórski M, Olewnik Ł.
europepmc   +1 more source

Machine learning model for fast prediction and uncertainty quantification of needle deflection during prostate biopsy

Medical Physics, Volume 53, Issue 2, February 2026.
Abstract Background Accurate needle placement is essential for prostate biopsy. Recently, transperineal prostate biopsies are receiving renewed interest due to concern over infection from conventional transrectal biopsies. However, accurate needle placement is more challenging in the transperineal approach than in the transrectal approach due to the ...
Nathan Hoffman, Lidia Al‐Zogbi, Axel Krieger, Junichi Tokuda, Pedro Moreira, Mark Fuge   +5 more
wiley   +1 more source

Integrative use of conventional mode and elastography in endobronchial ultrasound for the diagnosis of malignant intrathoracic lymphadenopathy. [PDF]

J Thorac Dis
Korrungruang P, Boonsarngsuk V, Pornsuriyasak P, Charernboon T.   +3 more
europepmc   +1 more source

Ultrasound Shear Wave Elastography for Noninvasive Diagnosis of Acute Compartment Syndrome Using a Novel In Vivo Turkey Model [PDF]

Ichiro Tsukamoto, Naoya Iida, Farbod Yousefi, Elameen Adam, Omar Selim, Gongyin Zhao, Rou Wan, Aida K. Sarcon, Chunfeng Zhao   +8 more
openalex   +1 more source

Ten‐Year Follow‐Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT‐II): Improved Clinical Outcome After Combination Therapy

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background Chronic delta hepatitis represents a major health burden. Until recently, pegylated interferon‐alfa‐2a (PEG‐IFNα) therapy was the only treatment option for patients infected with hepatitis D virus (HDV). The aim of this study was to evaluate 10‐year long‐term clinical and virological outcomes after 96 weeks of treatment with PEG ...
Cihan Yurdaydin, Julia Kahlhöfer, Florin Alexandru Caruntu, Kendal Yalcin, Selim Gürel, Ulus S. Akarca, Kathrin Sprinzl, Hans H. Bock, Jan‐Hendrik Bockmann, George V. Papatheodoridis, Uta Merle, Münevver Demir, Svenja Hardtke, Onur Keskin, Ramazan Idilman, Markus Cornberg, Heiner Wedemeyer, Anika Wranke   +17 more
wiley   +1 more source

Objective and Non-Invasive Evaluation of Fascial Layers Related to Surgical or Post-Traumatic Scars: A Systematic Review of the Literature. [PDF]

Life (Basel)
De Luca C, Sun Y, Stecco A, Fede C, Clair C, Pirri C, Trovarelli G, Stecco C.   +7 more
europepmc   +1 more source

Exploration of Multiple Non‐Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients with MASH

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 3, Page 396-404, February 2026.
This study investigated multiple non‐invasive tests (NIT) in a phase 2b study of patients with MASH and fibrosis treated with semaglutide. Findings revealed that semaglutide significantly improved NIT scores versus placebo from as early as 28 weeks. The results support the use of NITs to assess a treatment response to semaglutide.
Louise Maymann Nitze, Vlad Ratziu, Arun J. Sanyal, Vincent Wai‐Sun Wong, Clare Balendran, Jan Fleckner, Mette Skalshøi Kjær, Niels Krarup, Quentin M. Anstee   +8 more
wiley   +1 more source

Intraoperative elastography and spinal surgery: a systematic review of current and future applications in clinical and preclinical models. [PDF]

Ultrasound J
Dhillon P, Saway BF, Galimba A, Suresh R, Eckert T, Kerensky MJ, Vattipally VN, Kramer P, Theodore N, Patel S, Kalhorn S.   +10 more
europepmc   +1 more source

Accuracy of the Enhanced Liver Fibrosis Test vs FibroTest, Elastography, and Indirect Markers in Detection of Advanced Fibrosis in Patients With Alcoholic Liver Disease.

Gastroenterology, 2018
M. Thiele, B. Madsen, J. Hansen, S. Detlefsen, S. Antonsen, A. Krag   +5 more
semanticscholar   +1 more source

Non‐Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 4, Page 494-506, February 2026.
In a multi‐centre study of obeticholic acid in primary biliary cholangitis, 45% discontinued the drug over 4 years, with 11% moving to combination therapy (fibrates). Of those continuing, response rates increased from 37% (1 year) to 55% (4 years). Non‐response at 12 months and cirrhosis were independent predictors of liver‐related events.
Nadir Abbas, Rachel Smith, Ellina Lytvyak, Miki Scaravaglio, Neil Halliday, Amal Almahroos, Nadia Eden, Diane Lloyd‐Madden, Sanchit Sharma, James Ferguson, Jessica K. Dyson, Douglas Thorburn, David Jones, Aldo J. Montano‐Loza, Marco Carbone, Pietro Invernizzi, George Mells, Emma L. Culver, Palak J. Trivedi   +18 more
wiley   +1 more source